Pharmaceutical Company Diversifies into Stablecoins, Acquires 9% of SKY Token Supply

A major pharmaceutical firm has strategically shifted a portion of its treasury reserves into cryptocurrency, specifically focusing on stablecoins. In a significant move, the company has acquired nearly 9% of the total circulating supply of the SKY token. This pivot highlights the growing trend of traditional corporations entering the digital asset space to hedge against market volatility and explore new financial instruments. The substantial investment in SKY underscores the company's confidence in this specific asset's utility or potential within the stablecoin ecosystem. Analysts view this as a legitimizing signal for the crypto market, demonstrating institutional interest beyond Bitcoin and Ethereum. [news_title_rus=Фармацевтическая компания диверсифицирует активы в стейблкоины, приобретая 9% предложения токена SKY